Nevro to Present at the Canaccord Genuity 43rd Annual Growth Conference
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Stay updated with breaking news from Corp Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Barclays analyst Michael Leithead maintained a Hold rating on Chemours Company (CC – Research Report) today and set a price target of $40....
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
RTP, North Carolina, June 06, 2023 (GLOBE NEWSWIRE) -- For Immediate Release Contact: Steve Betz, Sr. Director of Corp Communications (515) 665-7683...